We are live on ! Find out more
KERX

Keryx Biopharmaceuticals Inc
KERX

Delisted

KERX was delisted on the 12th of December, 2018.

Back to rankings

153 hedge funds and large institutions have $915M invested in Keryx Biopharmaceuticals Inc in 2015 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 66 increasing their positions, 40 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 40

16% more call options, than puts

Call options by funds: $16.2M | Put options by funds: $13.9M

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 157 → 153 (-4)

14% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 28

23% less capital invested

Capital invested by funds: $1.19B → $915M (-$271M)

Holders
153
Holders Change
-4
Holders Change %
-2.55%
% of All Funds
4.12%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
24
Increased
66
Reduced
40
Closed
28
Calls
$16.2M
Puts
$13.9M
Net Calls
+$2.26M
Net Calls Change
+$3.99M

Top Buyers

Rank Fund Capital Flow
1
BG
Baupost Group
Massachusetts
+$36.6M
2
State Street
State Street
Massachusetts
+$10.8M
3
BGIM
Brandywine Global Investment Management
Pennsylvania
+$9.59M
4
Invesco
Invesco
Georgia
+$6.02M
5
EAM
Eagle Asset Management
Florida
+$5.96M

Top Sellers

Rank Fund Capital Flow
1
SAM
Sectoral Asset Management
Quebec, Canada
-$48.7M
2
CCM
Camber Capital Management
Massachusetts
-$26.8M
3
O
OppenheimerFunds
New York
-$12.3M
4
TCM
Tamarack Capital Management
California
-$12.1M
5
DM
Deerfield Management
New York
-$9.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
PIA
151
Piedmont Investment Advisors
North Carolina
$409 +$440 +41 New
FNBOO
152
First National Bank of Omaha
Nebraska
$121 – – –
SAM
153
Sectoral Asset Management
Quebec, Canada
– -$48.7M -3,825,256 Closed
O
154
OppenheimerFunds
New York
– -$12.3M -966,858 Closed
TCM
155
Tamarack Capital Management
California
– -$12.1M -950,000 Closed
DM
156
Deerfield Management
New York
– -$9.74M -765,450 Closed
First Manhattan
157
First Manhattan
New York
– -$7.64M -600,000 Closed
NC
158
Northpointe Capital
Michigan
– -$5.43M -426,849 Closed
CS
159
Candriam SCA
Luxembourg
– -$4.97M -390,000 Closed
BNP Paribas Asset Management
160
BNP Paribas Asset Management
France
– -$3.72M -292,478 Closed
PAMU
161
Pictet Asset Management (UK)
United Kingdom
– -$2.93M -274,900 Closed
EAM
162
EverPoint Asset Management
Connecticut
– -$3.18M -250,000 Closed
SFM
163
Sphera Funds Management
Israel
– -$2.93M -230,000 Closed
SO
164
STRS Ohio
Ohio
– -$961K -75,500 Closed
AA
165
ALPS Advisors
Colorado
– -$640K -50,296 Closed
TI
166
Turner Investments
Pennsylvania
– -$494K -38,790 Closed
PAM
167
Panagora Asset Management
Massachusetts
– -$466K -36,584 Closed
DCM
168
DAFNA Capital Management
California
– -$443K -34,800 Closed
SM
169
Southport Management
Wyoming
– -$255K -20,000 Closed
RJA
170
Raymond James & Associates
Florida
– -$250K -19,624 Closed
SKK
171
Shepherd Kaplan Krochuk
Massachusetts
– -$239K -18,766 Closed
SM
172
Sabby Management
Florida
– -$158K -14,758 Closed
NIT
173
NumerixS Investment Technologies
British Columbia, Canada
– -$187K -14,700 Closed
AG
174
Aperio Group
California
– -$134K -10,539 Closed
KB
175
Kimelman & Baird
New York
– -$127K -10,000 Closed
4 5 6
7
8

KERX Hedge Fund Activity: Q2 2015 in Review

153 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Keryx Biopharmaceuticals Inc (KERX) for Q2 2015, worth a combined $915M — down 23% from $1.19B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of KERX and 24 opened new positions — a net loss of 4 holders — while 40 trimmed existing stakes and 66 added.

The largest buyer was Baupost Group, adding an estimated $36.6M. The largest seller was Sectoral Asset Management, exiting entirely with an estimated $48.7M sold.

  • 153 institutional investors held Keryx Biopharmaceuticals Inc (KERX) as of Q2 2015, down from 157 in Q1 2015.
  • Funds reported $915M of Keryx Biopharmaceuticals Inc stock for Q2 2015, down 23% quarter-over-quarter.
  • 24 funds opened new Keryx Biopharmaceuticals Inc positions in Q2 2015 and 28 closed out, a net change of -4 holders.
  • The largest Keryx Biopharmaceuticals Inc buyer in Q2 2015 was Baupost Group, an estimated $36.6M added.
  • The largest Keryx Biopharmaceuticals Inc seller in Q2 2015 was Sectoral Asset Management, an estimated $48.7M sold.

Based on aggregated 13F filings for Q2 2015.